Avtor/Urednik		Laar, Marita J. W. van de; Bosman, Arnold; Pharris, Anastasia; Andersson, Emmi; Assoumou, Lambert; Ay, Eva; Bannert, Norbert; Bartmeyer, Barbara; Brady, Melissa; Poljak, Mario
Naslov		Piloting a surveillance system for HIV drug resistance in the European Union
Tip		članek
Vol. in št.		Letnik 24, št. 19
Leto izdaje		2019
Obseg		str. 1-7
ISSN		1560-7917 - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Jezik		eng
Abstrakt		BackgroundA steady increase in HIV drug resistance (HIVDR) has been demonstrated globally in individuals initiating first-line antiretroviral therapy (ART). To support effective use of ART and prevent spread of HIVDR, monitoring is essential.AimWe piloted a surveillance system for transmitted HIVDR to assess the feasibility of implementation at the European level.MethodAll 31 countries in the European Union and European Economic Area were invited to retrospectively submit data on individuals newly diagnosed with HIV in 2015 who were tested for antiviral susceptibility before ART, either as case-based or as aggregate data. We used the Stanford HIV database algorithm to translate genetic sequences into levels of drug resistance.ResultsNine countries participated, with six reporting case-based data on 1,680 individuals and four reporting aggregated data on 1,402 cases. Sequence data were available for 1,417 cases: 14.5% of individuals (n = 244) showed resistance to at least one antiretroviral drug. In case-based surveillance, the highest levels of transmitted HIVDR were observed for non-nucleoside reverse-transcriptase inhibitors (NNRTIs) with resistance detected in 8.6% (n = 145), followed by resistance to nucleoside reverse-transcriptase inhibitors (NRTI) (5.1%; n = 85) and protease inhibitors (2.0%; n = 34).ConclusionWe conclude that standard reporting of HIVDR data was feasible in the participating countries. Legal barriers for data sharing, consensus on definitions and standardisation of interpretation algorithms should be clarified in the process of enhancing European-wide HIV surveillance with drug resistance information.
Proste vsebinske oznake		HIV/AIDS resistance pilot study HIV/AIDS odpornost pilotna študija